What is the difference between attention‑deficit disorder (ADD) and attention‑deficit/hyperactivity disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

ADD vs. ADHD: Understanding the Terminology

"ADD" (Attention Deficit Disorder) is an outdated term that is no longer used in modern diagnostic classification; the current diagnosis is ADHD (Attention-Deficit/Hyperactivity Disorder), which encompasses three distinct presentations including one that matches what was previously called ADD. 1

Current Diagnostic Framework

The DSM-5 defines ADHD with four distinct presentations, not separate disorders 1:

  • ADHD, Predominantly Inattentive Presentation (314.00 [F90.0]) – This is what was historically called "ADD" and involves primarily inattention symptoms without significant hyperactivity 1
  • ADHD, Predominantly Hyperactive-Impulsive Presentation (314.01 [F90.1]) – Characterized by hyperactivity and impulsivity without prominent inattention 1
  • ADHD, Combined Presentation (314.01 [F90.2]) – Includes both inattentive and hyperactive-impulsive symptoms 1
  • ADHD, Other Specified and Unspecified (314.01 [F90.8]) – Used when symptoms cause impairment but full criteria cannot be verified 1

Why the Terminology Changed

ADHD is characterized by persistent symptoms of inattention, hyperactivity, and impulsivity, and the modern classification recognizes that these symptom domains exist on a spectrum rather than as separate disorders 2. The shift from "ADD" to "ADHD with presentations" reflects the understanding that:

  • All individuals with attention problems fall under the ADHD umbrella, regardless of whether hyperactivity is present 2
  • The predominantly inattentive presentation captures what was previously diagnosed as ADD 1
  • Symptom patterns can shift over time, particularly as hyperactive symptoms typically decline while inattentive symptoms persist into adulthood 3

Practical Clinical Implications

For diagnosis, clinicians must document at least 5 symptoms (in adults) or 6 symptoms (in children) of inattention and/or hyperactivity-impulsivity, with onset before age 12, and functional impairment in at least two settings 3, 4. The specific presentation is determined by which symptom domain predominates:

  • Inattentive symptoms include poor attention to detail, difficulty sustaining attention, appearing preoccupied, difficulty completing tasks, organizational challenges, and reluctance to engage in sustained mental effort 3
  • Hyperactive-impulsive symptoms include frequent fidgeting, difficulty sitting still, inner restlessness, being loud or disruptive, constant "on-the-go" feeling, and excessive talking 3

Common Pitfall to Avoid

Do not use the term "ADD" in clinical documentation or when communicating with patients, as it is not recognized in current diagnostic systems and may cause confusion about the actual diagnosis 1. Instead, specify "ADHD, predominantly inattentive presentation" when hyperactivity is absent 1.

Related Questions

In a 33‑year‑old woman with depression treated with sertraline 150 mg who is experiencing restlessness and anxiety after a new diagnosis of Attention‑Deficit/Hyperactivity Disorder and is taking quetiapine (Seroquel) 25 mg for sleep, how should her medication regimen be managed?
A 36-year-old woman with ADHD and depression who is taking bupropion (Wellbutrin XL) 300 mg daily presents with new onset irritability; what is the appropriate management?
In a 44‑year‑old male with depression treated with venlafaxine 150 mg daily and passive suicidal thoughts, who has been diagnosed with combined‑type attention‑deficit/hyperactivity disorder, what is the best treatment option for his ADHD?
Is Adderall indicated for treating fatigue, or is it only approved for attention‑deficit/hyperactivity disorder (ADHD) and narcolepsy?
What medication options are appropriate for a 14-year-old with anxiety and irritability being evaluated for attention-deficit/hyperactivity disorder (ADHD)?
How should I perform an initial psychiatric assessment?
How should I start atomoxetine (Strattera) in a patient with ADHD, including required screening, dosing, monitoring, and safety precautions?
How should I evaluate and manage a patient who developed dizziness after a fall?
How do triple‑negative breast cancer and hormone‑receptor‑positive breast cancer differ in biology, prognosis, and recommended treatment approaches?
What naproxen dose is equivalent to meloxicam 7.5 mg once daily in a patient without peptic ulcer disease, renal impairment, or heart failure?
When is early colonoscopy screening indicated for average‑risk adults and for individuals with a first‑degree relative with colorectal cancer or advanced adenoma, hereditary colorectal cancer syndromes (familial adenomatous polyposis, Lynch syndrome), long‑standing inflammatory bowel disease (ulcerative colitis or Crohn’s colitis), African‑American race, or a personal history of colorectal neoplasia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.